⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22929019 | 0.70 | — | — | |
| SCHEMBL26042060 | 0.70 | — | — | |
| SCHEMBL14275714 | 0.61 | — | — | |
| SCHEMBL13864427 | 0.60 | — | — | |
| SCHEMBL28143025 | 0.60 | — | — | |
| SCHEMBL347863 | 0.57 | — | — | |
| SCHEMBL9066651 | 0.57 | — | — | |
| SCHEMBL18911870 | 0.57 | — | — | |
| SCHEMBL31380149 | 0.57 | — | — | |
| SCHEMBL12275783 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3502119-A2 | IMMUNOMODULATING BETA-1,6-D-GLUCANS | Immunexcite, Inc. (US) | 2019-06-26 | — | — | EP | disclosed |